Novartis Ag (NVS) EBT Margin (QoQ) (2009 - 2023)
Novartis Ag (NVS) EBT Margin (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.40 Bn | 624.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.79 Bn | 456.22 Bn | 12.70 Bn |
| 3 | Merck | 369.55 Bn | 362.41 Bn | 12.21 Bn |
| 4 | Novartis Ag | 298.79 Bn | 291.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 255.57 Bn | 250.67 Bn | 12.86 Bn |
| 6 | Amgen | 233.87 Bn | 219.89 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 179.24 Bn | 176.06 Bn | 6.22 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 9 | Gsk | 104.53 Bn | 100.36 Bn | 8.24 Bn |
| 10 | Sanofi | 54.48 Bn | 47.10 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -154.35 Mn |
| Mar 31, 2023 | 154.35 Mn |
| Dec 31, 2022 | -35,385.00 |
| Sep 30, 2022 | 35,648.00 |
| Jun 30, 2022 | -1.32 Bn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 292,035.00 |
| Sep 30, 2021 | -292,394.00 |
| Jun 30, 2021 | -498.25 Mn |
| Mar 31, 2021 | 498.25 Mn |
| Dec 31, 2020 | -756.34 Mn |
| Sep 30, 2020 | 756.34 Mn |
| Jun 30, 2020 | -6,101.00 |
| Jun 30, 2019 | -18,995.00 |
| Mar 31, 2019 | -78,985.00 |
| Dec 31, 2018 | 34,964.00 |
| Sep 30, 2018 | 58,061.00 |
| Jun 30, 2018 | -22,382.00 |
| Mar 31, 2018 | 29,029.00 |
| Dec 31, 2017 | 547.00 |